Valuation: Biogen Inc.

Market Cap 36.71B 32.93B 30.09B 27.47B 51.75B 3,451B 53.39B 363B 145B 1,841B 138B 135B 5,813B P/E 2026 *
46.4x
P/E 2027 * 22.3x
Enterprise Value 42.35B 37.98B 34.71B 31.69B 59.7B 3,981B 61.58B 418B 167B 2,124B 159B 156B 6,705B EV / Sales 2026 *
4.02x
EV / Sales 2027 * 3.7x
Free-Float
85.81%
Yield 2026 *
-
Yield 2027 * -
1 day+1.81%
1 week-2.08%
Current month-2.08%
1 month+11.42%
3 months+20.39%
6 months+30.24%
Current year+41.12%
1 week 240
Extreme 240.0001
255.7
1 month 215.73
Extreme 215.73
258.78
Current year 160.36
Extreme 160.3645
258.78
1 year 153.77
Extreme 153.77
258.78
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 13/11/2022
Director of Finance/CFO 60 28/02/2025
Chief Tech/Sci/R&D Officer - 27/10/2024
Director TitleAgeSince
Director/Board Member 69 22/03/2010
Director/Board Member 77 31/12/2009
Director/Board Member 72 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Exercice

Controller/Auditor

62 0.0000%
01/09/26 Free

General Counsel

7,405 0.0050%
04/08/26 Sell

Director

-593 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.81%-2.08%+58.45%-0.11% 36.06B
-0.79%-4.48%+44.44%+127.49% 1,216B
+1.43%+1.11%+47.73%+82.08% 656B
+1.07%-1.21%+32.99%+106.31% 509B
-0.36%-2.84%+47.23%+64.51% 384B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%+0.59%+31.01%+59.68% 311B
-0.80%+6.73%+11.89%+35.64% 293B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 208B
Average +0.11%-0.55%+42.59%+69.07% 422.39B
Weighted average by Cap. -0.04%-1.22%+42.61%+87.72%

Financials

2026 *2027 *
Net sales 10.53B 9.44B 8.63B 7.88B 14.84B 990B 15.31B 104B 41.48B 528B 39.52B 38.67B 1,667B 10.76B 9.65B 8.82B 8.05B 15.17B 1,012B 15.65B 106B 42.4B 540B 40.4B 39.53B 1,704B
Net income 788M 707M 646M 590M 1.11B 74.07B 1.15B 7.79B 3.1B 39.52B 2.96B 2.89B 125B 1.79B 1.6B 1.46B 1.34B 2.52B 168B 2.6B 17.65B 7.04B 89.61B 6.71B 6.56B 283B
Net Debt 5.63B 5.05B 4.62B 4.22B 7.94B 530B 8.19B 55.67B 22.2B 283B 21.15B 20.69B 892B 3.08B 2.76B 2.53B 2.31B 4.34B 290B 4.48B 30.44B 12.14B 155B 11.56B 11.32B 488B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
06/11/26 US$248.35 +1.81% 1,002,116
05/11/26 US$243.93 -4.14% 1,221,066
04/11/26 US$254.46 +2.22% 1,348,003
03/11/26 US$248.93 -0.03% 1,057,628
02/11/26 US$249.01 -1.82% 1,172,994
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
248.35USD
Average target price
264.82USD
Spread / Average Target
+6.63%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biogen Inc.
  1. Stock Market
  2. Stocks
  3. BIIB Stock